{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:09:43Z","timestamp":1785240583574,"version":"3.55.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>This clinical report describes the beneficial effects of local subcutaneous injections of meglumine antimoniate (Glucantime\u00ae) on <jats:italic>Leishmania<\/jats:italic> cutaneous lesions in a dog from Calabria, a region of Southern Italy. Leishmaniasis is an endemic zoonotic disease in the European Union, particularly in Mediterranean countries, as well as in parts of north and east Africa, India, China, and Central and South America, caused by protozoa of the genus <jats:italic>Leishmania<\/jats:italic> spp., which infect several reservoirs, including humans and domestic animals. In southern Europe, the main etiological agent is <jats:italic>Leishmania infantum,<\/jats:italic> transmitted by sandflies of the subfamily Phlebotominae, which is the most common cause of cutaneous leishmaniasis (CL) in these regions, where dogs are considered the primary domestic reservoir of the parasite. A 7-year-old male non-sterilized Boxer named Ettore underwent pre-vaccination blood tests and Leishmania indirect immunofluorescence (IFI) test, which confirmed the presence of antibodies against the protozoan <jats:italic>Leishmania infantum<\/jats:italic> (antibody titer, 1:1280), supporting the diagnosis of CL. The dog underwent a therapeutic protocol consisting of miltefosine (Milteforan\u2122 - Virbac\u00ae) (2\u202fmg\/Kg b.w. per os) for 28\u202fdays and allopurinol 300\u202fmg (10\u202fmg\/Kg b.w. po) for 6\u202fmonths. However, at the end of the treatment period, the appearance of a suspicious skin lesion on the left tarsus was reported, which appeared inflamed and infected. The subsequent antibiotic and anti-inflammatory therapy based on amoxicillin+clavulanic acid (12.5\u202fmg\/kg b.w. po for 15\u202fdays), metronidazole (75000UI\u202f+\u202f12.5\u202fmg po for 15\u202fdays), and prednisone (0.5\u202fmg\/kg b.w. po for 10\u202fdays) failed to be effective; thus, the lesion worsened and also spread to the dorsal femoral surface of both hind limbs, presenting as blackish, swollen, painful, alopecic and oozing bloody and purulent material. Mild renal microlithiasis and splenopathy were reported by abdominal ultrasound and were associated with a possible leishmania pattern. Finally, skin lesions were experimentally treated with subcutaneous injections of Glucantime\u00ae (200\u202fmg\/lesion \u2013 0.5\u202fmL\/lesion) once a month for 5\u202fmonths, followed by complete healing. Interestingly, the experimental localized treatment with Glucantime\u00ae proved to be crucial in counteracting Leishmania skin lesions. The results obtained suggest that, through an appropriate diagnosis, it is possible to define targeted and effective therapeutic protocols useful in the management of canine leishmaniasis.<\/jats:p>","DOI":"10.3389\/fvets.2025.1600004","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:58:20Z","timestamp":1751302700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of meglumine antimoniate treatment on boxer Leishmania infantum skin lesions: case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Cristina","family":"Carresi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Francesca","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyndi","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Coppoletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cardamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Gliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mollace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Britti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3201\/eid2706.210239","article-title":"Leishmaniases in the European Union and neighboring countries","volume":"27","author":"Berriatua","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s11259-023-10171-5","article-title":"Is leishmaniasis the new emerging zoonosis in the world","volume":"47","author":"Montaner-Angoiti","year":"2023","journal-title":"Vet Res Commun"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e3131","DOI":"10.1371\/journal.pntd.0003131","article-title":"Visceral leishmaniasis in Ethiopia: an evolving disease","volume":"8","author":"Leta","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1371\/journal.pntd.0000259","article-title":"Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan","volume":"2","author":"Kassi","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","article-title":"Cutaneous leishmaniasis: recent developments in diagnosis and management","volume":"16","author":"de Vries","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12879-021-06327-w","article-title":"Cutaneous Leishmaniasis in Pakistan: a neglected disease needing one health strategy","volume":"21","author":"Kayani","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0004349","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref13","volume-title":"Leishmaniasis","year":"2022"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1007526401175","article-title":"Asymptomatic canine leishmaniasis in greater Athens area, Greece","volume":"15","author":"Sideris","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0304-4017(99)00074-6","article-title":"Epidemiology of canine leishmaniosis in Catalonia (Spain) the example of the Priorat focus","volume":"83","author":"Fisa","year":"1999","journal-title":"Vet Parasitol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.biocon.2012.07.005","article-title":"A review of the interactions between free-roaming domestic dogs and wildlife","volume":"157","author":"Hughes","year":"2013","journal-title":"Biol Conserv"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"102211","DOI":"10.1016\/j.cimid.2024.102211","article-title":"Canine leishmaniosis global prevalence over the last three decades: a meta-analysis and systematic review","volume":"112","author":"Priolo","year":"2024","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-ento-120811-153557","article-title":"Biology of phlebotomine sand flies as vectors of disease agents","volume":"58","author":"Ready","year":"2013","journal-title":"Annu Rev Entomol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1354\/vp.42-2-166","article-title":"Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response","volume":"42","author":"Brachelente","year":"2005","journal-title":"Vet Pathol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF00144813","article-title":"Canine leishmaniasis in the Gargano promontory (Apulia, South Italy)","volume":"8","author":"Brandonisio","year":"1992","journal-title":"Eur J Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4269\/ajtmh.1996.55.273","article-title":"Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting","volume":"55","author":"Berrahal","year":"1996","journal-title":"Am J Trop Med Hyg."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0304-4017(97)00208-2","article-title":"The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs","volume":"76","author":"Cabral","year":"1998","journal-title":"Vet Parasitol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1128\/JCM.39.2.560-563.2001","article-title":"Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology","volume":"39","author":"Solano-Gallego","year":"2001","journal-title":"J Clin Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.pt.2017.05.005","article-title":"Novel areas for prevention and control of canine leishmaniosis","volume":"33","author":"Mir\u00f3","year":"2017","journal-title":"Trends Parasitol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4269\/ajtmh.2002.67.511","article-title":"Domestic dog ownership in Iran is a risk factor for human infection with Leishmania infantum","volume":"67","author":"Gavgani","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1111\/j.1365-3156.2006.01747.x","article-title":"Leishmania and sand flies: proximity to woodland as a risk factor for infection in a rural focus of visceral leishmaniasis in west Central Venezuela","volume":"11","author":"Feliciangeli","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"LeishVet guidelines for the practical management of canine leishmaniosis","volume":"4","author":"Solano-Gallego","year":"2011","journal-title":"Parasit Vectors"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.trstmh.2005.07.011","article-title":"Mixed infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi in a naturally infected dog from Rio de Janeiro, Brazil","volume":"100","author":"Madeira","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref29","year":"2010"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1590\/S0034-8910.2014048005615","article-title":"Visceral leishmaniasis in Brazil: rationale and concerns related to reservoir control","volume":"48","author":"Werneck","year":"2014","journal-title":"Rev Saude Publica"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol Biol Int"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/vetsci9080387","article-title":"Canine Leishmaniasis: update on epidemiology, diagnosis, treatment, and prevention","volume":"9","author":"Morales-Yuste","year":"2022","journal-title":"Vet Sci."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/ani14152244","article-title":"Treatment of canine Leishmaniasis with Meglumine Antimoniate: a clinical study of tolerability and efficacy","volume":"14","author":"Digiaro","year":"2024","journal-title":"Animals"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.tvjl.2010.05.025","article-title":"Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol","volume":"188","author":"Torres","year":"2011","journal-title":"Vet J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3855\/jidc.10050","article-title":"Tolerability and pharmacokinetics of two antimony products after subcutaneous administration in dogs","volume":"12","author":"Rambaldi","year":"2018","journal-title":"J Infect Dev Ctries"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00436-009-1375-3","article-title":"Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis","volume":"105","author":"Mateo","year":"2009","journal-title":"Parasitol Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1177\/0192623309344088","article-title":"Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys","volume":"37","author":"Bianciardi","year":"2009","journal-title":"Toxicol Pathol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/vetsci7030128","article-title":"Prognostic factors and life expectancy in canine leishmaniosis","volume":"7","author":"Pereira","year":"2020","journal-title":"Vet Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment","volume":"86","author":"Gramiccia","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"577395","DOI":"10.3389\/fvets.2020.577395","article-title":"Comparison of two dosing regimens of Miltefosine, both in combination with allopurinol, on clinical and parasitological findings of dogs with leishmaniosis: a pilot study","volume":"7","author":"Iarussi","year":"2020","journal-title":"Front Vet Sci."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/cid\/ciy747","article-title":"Pharmacokinetics, safety, and efficacy of an Allometric Miltefosine regimen for the treatment of visceral Leishmaniasis in eastern African children: an open-label, phase II clinical trial","volume":"68","author":"Mbui","year":"2019","journal-title":"Clin Infect Dis"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-3164.2005.00460.x","article-title":"Treatment of canine Old World visceral leishmaniasis: a systematic review","volume":"16","author":"Noli","year":"2005","journal-title":"Vet Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.tvjl.2008.08.009","article-title":"Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis","volume":"182","author":"Manna","year":"2009","journal-title":"Vet J"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1756-3305-4-52","article-title":"Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments","volume":"4","author":"Mir\u00f3","year":"2011","journal-title":"Parasit Vectors"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0165-2427(02)00128-9","article-title":"Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis","volume":"88","author":"Guarga","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13071-018-2705-z","article-title":"Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound","volume":"11","author":"Segarra","year":"2018","journal-title":"Parasit Vectors"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13071-019-3323-0","article-title":"Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil","volume":"12","author":"Dos Santos Nogueira","year":"2019","journal-title":"Parasit Vectors"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fvets.2019.00362","article-title":"Meglumine Antimoniate and Miltefosine combined with allopurinol sustain pro-inflammatory immune environments during canine leishmaniosis treatment","volume":"6","author":"Santos","year":"2019","journal-title":"Front Vet Sci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.tvjl.2014.09.002","article-title":"An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. Chagasi)","volume":"202","author":"Noli","year":"2014","journal-title":"Vet J"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tvjl.2009.09.011","article-title":"Clinical and laboratory monitoring of dogs naturally infected by Leishmania infantum","volume":"186","author":"Paradies","year":"2010","journal-title":"Vet J"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13071-015-0896-0","article-title":"Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol","volume":"8","author":"Manna","year":"2015","journal-title":"Parasit Vectors"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e015023","DOI":"10.1590\/s1984-29612024012","article-title":"Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum","volume":"33","author":"Gon\u00e7alves","year":"2024","journal-title":"Rev Bras Parasitol Vet"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.vetpar.2011.05.009","article-title":"Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil","volume":"181","author":"Andrade","year":"2011","journal-title":"Vet Parasitol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s13071-021-05100-x","article-title":"Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol","volume":"14","author":"Gon\u00e7alves","year":"2021","journal-title":"Parasit Vectors"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity","volume":"53","author":"Kumar","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.vetpar.2016.07.011","article-title":"Current status on prevention and treatment of canine leishmaniasis","volume":"227","author":"Reguera","year":"2016","journal-title":"Vet Parasitol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1365-4362.1997.00188.x","article-title":"Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission","volume":"36","author":"Oliveira-Neto","year":"1997","journal-title":"Int J Dermatol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1590\/0037-8682-0213-2016","article-title":"Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis","volume":"49","author":"Duque","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.actatropica.2019.03.007","article-title":"Comparison between systemic and intralesional meglumine antimoniate therapy in a primary health care unit","volume":"193","author":"de Oliveira Duque","year":"2019","journal-title":"Acta Trop"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4269\/ajtmh.2012.11-0612","article-title":"Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006)","volume":"87","author":"Vasconcellos","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref65","first-page":"1","article-title":"Report of a WHO expert committee","volume":"793","year":"1990","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref66","first-page":"1","article-title":"Report of a WHO expert committee","volume-title":"World health organ tech rep Ser","year":"2010"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"e0184777","DOI":"10.1371\/journal.pone.0184777","article-title":"Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: a systematic review","volume":"12","author":"Brito","year":"2017","journal-title":"PLoS One"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e0244923","DOI":"10.1371\/journal.pone.0244923","article-title":"Seroprevalence and risk factors associated with exposure to Leishmania infantum in dogs, in an endemic Mediterranean region","volume":"16","author":"Rombol\u00e0","year":"2021","journal-title":"PLoS One"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40262-017-0570-0","article-title":"Clinical pharmacokinetics of systemically administered Antileishmanial drugs","volume":"57","author":"Kip","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1590\/0037-8682-0323-2016","article-title":"Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities","volume":"50","author":"Pimentel","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"852","DOI":"10.4269\/ajtmh.15-0640","article-title":"Intralesional Pentamidine: a novel therapy for single lesions of Bolivian cutaneous Leishmaniasis","volume":"94","author":"Soto","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1051\/parasite\/1998052175","article-title":"N-methylglucamine antimonate (SbV+): intralesional canine tegumentary leishmaniasis therapy","volume":"5","author":"Barbosa Santos","year":"1998","journal-title":"Parasite"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e0011064","DOI":"10.1371\/journal.pntd.0011064","article-title":"Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: a randomized controlled trial","volume":"17","author":"Lago","year":"2023","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1600004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:58:25Z","timestamp":1751302705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1600004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":74,"alternative-id":["10.3389\/fvets.2025.1600004"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1600004","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"article-number":"1600004"}}